Drug controller approves Phase 1, 2 trials of India’s first COVID-19 vaccine candidate

Human clinical trials in India are scheduled to start by July 2020

Drug controller approves Phase 1, 2 trials of India’s first COVID-19 vaccine candidate

Photo for representation only.

Aditi Tandon
Tribune News Service
New Delhi, June 30

India’s first COVID-19 Vaccine—COVAXIN, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, on Tuesday received the approval for phase one and two human clinical trials from the Drug Controller General of India.

Bharat Biotech has developed COVAXIN in association with ICMR’s National Institute of Virology (NIV) Pune.

The SARS-CoV-2 strain was isolated at NIV, Pune and transferred to Bharat Biotech.

The indigenous, inactivated vaccine developed and manufactured in Bharat Biotech’s Bio-Safety Level-3 High Containment facility located in Genome Valley, Hyderabad.

The Drug Controller General of India granted permission to initiate Phase I & II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response.

Human clinical trials in India are scheduled to start by July 2020.

Announcing the vaccine development milestone, Dr Krishna Ella, Chairman and Managing Director said: “We are proud to announce COVAXIN, India’s first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine. The proactive support and guidance from CDSCO have enabled approvals to this project. Our R&D and Manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform.”

Expedited through national regulatory protocols, the company accelerated its objective in completing the comprehensive pre-clinical studies.

Results from these studies have been promising and show extensive safety and effective immune responses.

Top Stories

Defence Council approves acquisition of fighter aircraft, missiles worth Rs 38,900 cr

Defence Council approves acquisition of fighter aircraft, missiles worth Rs 38,900 cr

Equipment to be manufactured in India; involve several MSMEs...

Eastern Ladakh standoff: Chinese side says progress made, India for quick end to build-up

Eastern Ladakh standoff: Chinese side says progress made, India for quick end to build-up

We expect China to ensure expeditious restoration of peace a...

Marines should be tried in Italy for Indian fishermen’s killing: Hague court

Marines should be tried in Italy for Indian fishermen’s killing: Hague court

Agrees kin of killed fishermen entitled to compensation

NHRC asks J-K, Ladakh to inform it about custodial deaths within 24 hrs

NHRC asks J-K, Ladakh to inform it about custodial deaths within 24 hrs

Encounter deaths to be reported within 2 days; seeks complia...

Lightning kills 31 in UP, Bihar; flood claims 1 life in Assam as Mumbai braces for heavy rain

Lightning kills 31 in UP, Bihar; flood claims 1 life in Assam as Mumbai braces for heavy rain

In view of the IMD alert, Mumbai Police have advised citizen...

Cities

View All